This article provides examples of how AI is helping to shape drug discovery, from drug design through to clinical trials.

Integrating AI tools into drug discovery introduces a mix of opportunities and challenges for startups and large pharmaceutical companies.

On January 6, 2025, the U.S. Food and Drug Administration (FDA) released draft guidance titled Considerations for the Use of Artificial ...

Nvidia said that it has partnered with companies and organizations in the life sciences industry to use generative AI to ...

Researchers at the University of Oklahoma have developed a breakthrough method of adding a single nitrogen atom to molecules, ...

The $20 million deal gives the chip supplier a toehold in the life-sciences market, a strategy it plans to replicate in other ...

Drug pricing is influenced by numerous factors, but technology has the potential to strike the critical balance between ...

IQVIA, Illumina, Mayo Clinic and Arc Institute Harness NVIDIA AI and Accelerated Computing to Transform $10 Trillion ...

(THE CONVERSATION) The potential of using artificial intelligence in drug discovery and development has sparked both excitement and skepticism among scientists, investors and the general public.

Hallucinations are a persistent problem in healthcare. Here's how GSK is using test-time compute scaling to improve its gen AI systems.

A man was arrested after a bomb and drugs were found in his possession at an Anderson County hotel. Read more: ...

Insilico Medicine (“Insilico”), a clinical stage generative artificial intelligence (AI)-driven biotechnology company has ...